Key Findings:  This analysis of postmenopausal dyspareunia discusses several causes of, and muultiple treatment options that are being considered, including lubricants, moisturizers, vaginal estrogen, ospemifene, dehydroepiandrosterone, local testosterone therapy, cannabidiol, and fractional CO 2 laser treatments.
Type of Study:  Meta-analysis
Study Result:  Positive
Research Location(s):  United States
Year of Pub:  2023
Cannabinoids Studied:  Cannabidiol (CBD), Pharma CBD
Phytocannabinoid Source:  Not Applicable
Chemotype:  Chemotype III
Ligands Studied:  Estrogen
Route of Administration:  Topical
Citation:  Streicher LF. Diagnosis, causes, and treatment of dyspareunia in postmenopausal women. Menopause. 2023 Jun 1;30(6):635-649. doi: 10.1097/GME.0000000000002179. Epub 2023 Apr 11. PMID: 37040586.